Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

HHS, RFK sued by medical associations over COVID policy shift
Multiple professional groups, including the American Academy of Pediatrics and the American College of Physicians, challenge recent policy changes to vaccine recommendations for COVID-19, which end routine inoculations for minors and pregnant women.
New TAVR valve from MiRus linked to positive early outcomes
The Siegel TAVR valve includes no nickel or cobalt. In fact, its frame was built using special alloys specifically developed by MiRus.
EHR-driven PCI risk assessments could make a world of difference
Researchers with Mayo Clinic have shown that EHR-driven risk assessments could go a long way toward improving care for PCI patients.
FDA expands approval of Boston Scientific’s Farapulse PFA system
The FDA's 2024 approval of the Farapulse system covered patients with paroxysmal atrial fibrillation. Now, however, the technology is officially approved for patients with more persistent symptoms.
No biopsy required: Blood test could spot signs of rejection in heart transplant recipients
It may not always be necessary to subject heart transplant patients to one biopsy after another.

FDA finalizes new heart warnings for COVID-19 vaccines

The new warnings, first proposed to Pfizer and Moderna in April, are now officially required by the FDA. They provide additional information about the potential risks of myocarditis and/or pericarditis associated with these vaccines.

How the shape, size and location of calcified carotid plaques affect stroke risk

A new analysis provides further insight into factors affecting plaque stability and subsequent ischemic events

New report raises questions about data that helped heart drug gain FDA approval

Ticagrelor, an antiplatelet medication from AstraZeneca commonly prescribed by cardiologists, gained FDA approval back in 2011. The author of a new investigative report, however, is raising several concerns about the data used to secure that approval.

Semaglutide, tirzepatide and other GLP-1 drugs appear to provide significant value for patients with moderate PAD.

The Evoque transcatheter tricuspid valve replacement (TTVR) system for tricuspid regurgitation from Edwards Lifesciences

TTVR with Evoque system linked to positive real-world outcomes after 30 days

According to early real-world data, the FDA-approved Evoque TTVR device is associated with positive outcomes when used to treat severe tricuspid regurgitation.

FDA alerts public to Medtronic device recall after 33 injuries

An urgent device recall has been issued on Bravo CF, a line of pH capsules that are placed in the esophagus to aid in understanding the effects of acid reflux. Due to a dangerous manufacturing error, certain lots of the devices must be quarantined immediately.

EnCompass F2 device from Nevada-based EnCompass Technologies

A closer look at world’s first TAVR patient treated with new cerebral embolic protection device

The device covers three vessels at once and can be deployed through the patient's TAVR access site. Researchers shared their first-in-human experience in JACC: Case Reports.

Society of Thoracic Surgeons provides on-the-go risk evaluations with new mobile app

The STS Risk Calculator App, available on both iOS and Android devices, gives users improved access to real-time risk assessments.

Clinical

HHS, RFK sued by medical associations over COVID policy shift

New TAVR valve from MiRus linked to positive early outcomes

EHR-driven PCI risk assessments could make a world of difference

FDA expands approval of Boston Scientific’s Farapulse PFA system

No biopsy required: Blood test could spot signs of rejection in heart transplant recipients